Which has grown faster, ARCT or IRD?

Over the past five years, IRD grew revenue faster — ARCT at a 22.30% CAGR versus IRD at 150.49%.

Arcturus Therapeutics Holdings Inc. (ARCT) vs Opus Genetics, Inc. (IRD)

A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and Opus Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ARCT

Arcturus Therapeutics Holdings Inc.

$373M

$13.14HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

IRD

Opus Genetics, Inc.

$360M

$4.37HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — ARCT vs IRD

growth of $100 · dividends reinvested · last 2y

ARCT -28.9% (-15.7%/yr)IRD +239.5% (+84.3%/yr)IRD compounded faster over this window

ARCT IRD

ARCT vs IRD: by the numbers

•ARCT is the larger company ($373M vs $360M market cap).
•Both run net losses; ARCT's is the smaller (-391.90% vs -1091.82% net margin).
•IRD grew revenue faster over the past five years (150.49% vs 22.30% CAGR).

Metrics side by side

Valuation

Metric	ARCT	IRD
P/S ratio	15.69	36.57
P/B ratio	2.17	N/A

Profitability

Metric	ARCT	IRD
Gross margin	95.50%	99.87%
Operating margin	-111.51%	-271.90%
Net margin	-391.90%	-1091.82%
ROE	-54.29%	N/A
ROIC	-54.07%	-59.29%

Growth (annualized)

Metric	ARCT	IRD
Revenue CAGR (5Y)	22.30%	150.49%
Total return CAGR (5Y)	-18.73%	N/A

Frequently asked

Which has grown faster, ARCT or IRD?: Over the past five years, IRD grew revenue faster — ARCT at a 22.30% CAGR versus IRD at 150.49%.

Go deeper

Full ARCT analysis Full IRD analysis Interactive comparison tool

Dig into the metrics

Arcturus Therapeutics ROE Opus Genetics ROE Arcturus Therapeutics operating margin Opus Genetics operating margin Arcturus Therapeutics revenue growth Opus Genetics revenue growth Arcturus Therapeutics free cash flow Opus Genetics free cash flow

Arcturus Therapeutics & Opus Genetics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.